Company intelligence / Profile preview

Intactis Bio Corp

Salt Lake City, Utah, United Statesaltitudelab.org ↗

Ownership: Private
Development stage: Preclinical

Overview

Intactis Bio Corp develops large-scale biomanufacturing methods to fabricate intact, vascularized tissues—primarily targeting functioning brain tissue for regenerative medicine. Their technology also enables "biocomputation," leveraging living neuronal networks as ultra-efficient computational substrates. The company claims significant advances in process development and regulatory readiness while aiming to commercialize both therapeutic products and a novel computation platform. Clinical results are not yet published; the company appears preclinical or at an early clinical/prototype stage.

Therapeutic areas: OtherNeurology
Modalities: Tissue engineering (large-scale tissue fabrication)Biocomputation using neuronal tissues
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Intactis Bio Corp.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intactis Bio Corp.

Explore the full profile